Athenex

Business Data, Corporate Office and Headquarter Address

About

Athenex is Biotechnology in United States that focus on Src Kinase inhibition business. Founded in 2003. They cover business area such as Athenex Inc, development, commercialization, novel therapy, cancer, its current clinical pipeline, Orascovery, a p-glycoprotein, (p-gp, inhibitor, Src Kinase inhibition, arginine deprivation therapy technology platform, corporate collaborator, licensing, pharmaceutical compound, recruiting personnel, additional drug candidate, acquisition, capital.

Business Type

Biotechnology

Country

United States

Founded

2003
( 21 years old in 2024 )

Company Focus

Src Kinase Inhibition

Website

-

Corporate Office and Headquarter Office address:

Conventus Building 1001 Main Street
Suite 600
Buffalo, NY 14203
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

Athenex Incdevelopmentcommercializationnovel therapycancerits current clinical pipelineOrascoverya p-glycoprotein(p-gpinhibitor, Src Kinase inhibitionarginine deprivation therapy technology platformcorporate collaboratorlicensingpharmaceutical compoundrecruiting personneladditional drug candidateacquisitioncapital

* We use standard office opening hours in near Athenex's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Athenex Frequently Asked Questions

What or who is Athenex?

Athenex is Biotechnology business from United States that founded in 2003 (21 years old in 2024), Athenex business is focusing on Src Kinase Inhibition.

Where is Athenex headquarter and corporate office address?

Athenex headquarter office and corporate office address is located in Conventus Building 1001 Main Street Suite 600 Buffalo, NY 14203 United States.

Where is Athenex country origins?

Athenex was founded in United States.

What is Src Kinase Inhibition business focus on?

In 2024, Athenex is currently focus on Src Kinase inhibition sector.

Src Kinase Inhibition Business Interest from Google Trend

Above is snippet of Google Trends for "Src Kinase inhibition" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Athenex, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.